A J Olah

Author PubWeight™ 17.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology 1977 1.11
2 Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease. Metabolism 1977 0.93
3 Effects of prolonged administration of metiamide on serum gastrin, gastrin content of the antrum and gastric corpus, and G-cell population in the rat. Gastroenterology 1979 0.89
4 Craniometaphyseal dysplasia with increased bone turnover and secondary hyperparathyroidism: therapeutic effect of calcitonin. J Pediatr 1988 0.89
5 [Differential diagnosis of metabolic bone diseases (author's transl)]. Orthopade 1982 0.89
6 Osteosclerosis in hyperparathyroidism. Radiology 1972 0.89
7 Temporal dynamics of healing in rabbit cranial defects using guided bone regeneration. J Oral Maxillofac Surg 1995 0.87
8 Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. Br J Rheumatol 1996 0.87
9 Membrane permeability is unnecessary for guided generation of new bone. An experimental study in the rabbit. Clin Oral Implants Res 1994 0.87
10 The biological effect of natural bone mineral on bone neoformation on the rabbit skull. Clin Oral Implants Res 1997 0.85
11 Effects of microscopic resolution on histomorphometrical estimates of structural and remodeling parameters in cancellous bone. Pathol Res Pract 1980 0.83
12 Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study. Horm Metab Res 1974 0.83
13 Osseous healing of experimentally created defects in the calvaria of rabbits using guided bone regeneration. A pilot study. Clin Oral Implants Res 1992 0.80
14 Blood-filled spaces with and without filler materials in guided bone regeneration. A comparative experimental study in the rabbit using bioresorbable membranes. Clin Oral Implants Res 1997 0.80
15 A novel model system for the study of experimental guided bone formation in humans. Clin Oral Implants Res 1996 0.79
16 Growth hormone in osteoporosis. Calcif Tissue Res 1976 0.78
17 Is secondary hyperparathyroidism an important etiologic factor in the anemia of chronic renal failure? Isr J Med Sci 1982 0.78
18 Differential staining of calcified tissues in plastic embedded microtome sections by a modification of Movat's pentachrome stain. Stain Technol 1977 0.77
19 [Hypoparathyroidism. Solved and unsolved pathologic physiological problems]. Dtsch Med Wochenschr 1968 0.77
20 [Changes of bone volume and bone structure in human ribs and their relationship to age and sex]. Acta Anat (Basel) 1969 0.76
21 [Diagnostic possibilities of histological bone morphometry]. Internist (Berl) 1975 0.76
22 Calcitonin in human osteoporosis. Results of prolonged administration, assessed by metabolic balance and quantitative histologic techniques. Isr J Med Sci 1971 0.75
23 [Pathogenesis, prevention and therapy of steroid osteoporosis]. Z Orthop Ihre Grenzgeb 1990 0.75
24 [Clinical aspects of bone metabolism -- correlations to bone morphology (report) (author's transl)]. Verh Dtsch Ges Pathol 1974 0.75
25 Quantitative relations between osteoblasts and osteoid in primary hyperparathyroidism, intestinal malabsorption ad renal osteodystrophy. Virchows Arch A Pathol Pathol Anat 1973 0.75
26 Bone remodeling in primary hyperparathyroidism. Preoperative and postoperative studies. Isr J Med Sci 1971 0.75
27 What is osteomalacia? Adv Exp Med Biol 1980 0.75
28 [Anatomic basis of shoulder and arm pain]. Ther Umsch 1988 0.75
29 [Histomorphometry of bone (report) (author's transl)]. Verh Dtsch Ges Pathol 1974 0.75
30 [The differential diagnosis of hypercalcitoninism]. Schweiz Med Wochenschr 1981 0.75
31 [Effect of long-term metiamide treatment on gastric secretion and on mucosal cells in the rat]. Verh Dtsch Ges Inn Med 1978 0.75
32 [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy]. Schweiz Med Wochenschr 1979 0.75
33 Histological effects of calcitonin in bone diseases. Calcif Tissue Res 1970 0.75
34 [Osteomalacia after intestinal operations--therapeutic effect of calcitriol. Report of a case]. Schweiz Med Wochenschr 1986 0.75
35 [Calcintonin--an antiosteoporosis hormone?]. Helv Med Acta Suppl 1970 0.75
36 [Muscle weakness and diffuse muscle pain. Osteomalacia, osteoporosis, L4-L5 intervertebral disc displacement]. Praxis (Bern 1994) 1999 0.75
37 [Symptoms and recent findings in pseudo-hypoparathyroidism (author's transl)]. Med Klin 1974 0.75
38 Mode of thyrocalcitonin action in man. Calcif Tissue Res 1968 0.75
39 [Isolated bone marrow mastocytosis: a rare cause of osteoporosis not to be missed]. Schweiz Rundsch Med Prax 1994 0.75
40 [Calcitonin. Research and clinical aspects]. Internist (Berl) 1971 0.75
41 Renal osteodystrophy in end-stage renal failure patients in Israel. Isr J Med Sci 1983 0.75
42 [Proceedings: Long-term treatment of osteoporosis using sodium fluoride and vitamin D3]. Helv Med Acta 1974 0.75
43 [Drug treatment of osteoporosis]. Ther Umsch 1977 0.75
44 [Osteoporoses. Bone morphology and bone metabolism]. Ther Umsch 1977 0.75
45 [Metabolic rates and histological-morphometrical investigations in bones of patients wtth osteoporosis subjected to long-term application of calcitonin]. Acta Endocrinol Suppl (Copenh) 1971 0.75
46 [Calcification disorders of the skeleton]. Internist (Berl) 1975 0.75